The hypoglycemic and hypolipidemic effects on GDM mice were suggested to have been exerted, at least in part, via the modulation of the AMP-activated protein kinase (AMPK)/peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) signaling pathway. The gene discussed is PPARGC1A; the disease is gestational diabetes.